Ee Ting Ng
Director/Board Member at Invitrocue Pte Ltd.
Profile
Ee Ting Ng is a Non-Executive Director at Invitrocue Pte Ltd.
She previously worked as a Non-Executive Director at Invitrocue Ltd.
from 2015 to 2019 and as a Director at BPH Global Ltd.
from 2018 to 2020.
Ee Ting Ng active positions
Companies | Position | Start |
---|---|---|
Invitrocue Pte Ltd.
Invitrocue Pte Ltd. BiotechnologyHealth Technology Invitrocue Pte Ltd. provides products and services in the fields of in vitro drug metabolism and pharmacokinetics (DMPK), in vitro toxicology, and digital pathology utilizing cell-based models and image analytics. It also offers realms of drug testing and research and development of cosmeceuticals and medical devices solutions. The firm’s technology also provides cuepath platform, web-based platform, view share, manage, and analyze virtual slides and information. The company was founded by Steven Fang in 2012 and is headquartered in Singapore. | Director/Board Member | - |
Former positions of Ee Ting Ng
Companies | Position | End |
---|---|---|
BPH GLOBAL LTD | Director/Board Member | 30/03/2020 |
INVITROCUE LIMITED | Director/Board Member | 14/10/2019 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BPH GLOBAL LTD | Health Technology |
Private companies | 2 |
---|---|
Invitrocue Ltd.
Invitrocue Ltd. Medical/Nursing ServicesHealth Services Invitrocue Ltd. engages in the provision of bio analytic solutions including in vitro cell-based testing technologies and image analytics software for use in digital pathology. The firm focuses on the commercialization of its bio analytics services using cell based model and imaging based technology. The company was founded by Steven Fang Boon Sing and Hanry Yu in 2012 and is headquartered in Sydney, Australia. | Health Services |
Invitrocue Pte Ltd.
Invitrocue Pte Ltd. BiotechnologyHealth Technology Invitrocue Pte Ltd. provides products and services in the fields of in vitro drug metabolism and pharmacokinetics (DMPK), in vitro toxicology, and digital pathology utilizing cell-based models and image analytics. It also offers realms of drug testing and research and development of cosmeceuticals and medical devices solutions. The firm’s technology also provides cuepath platform, web-based platform, view share, manage, and analyze virtual slides and information. The company was founded by Steven Fang in 2012 and is headquartered in Singapore. | Health Technology |
- Stock Market
- Insiders
- Ee Ting Ng